Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising the anti-EGFR monoclonal antibody depatuxizumab linked to the cytotoxic agent monomethyl auristatin E (MMAE). This ADC effectively suppresses the growth of xenograft models harboring both
Target:
Antibody-Drug Conjugates (ADCs)|||Others
* VAT and and shipping costs not included. Errors and price changes excepted
